Sorry everyone, am dealing with the rains here in DC. Will be in full force next week! Share this:
I’ve been on the road traveling for several days and lots has been happening. The occasion of the 100th anniversary of the FDA’s existence has sparked a great deal of commentary. Gang up! Remarkably, all on the same day, Public … Continue reading
You have to admire Washington. It is the only city in the United States where, when you don’t do anything, you make news. At least if your name is Supreme Court. Monday the Associated Press noted that the Supremes have … Continue reading
When an investigational product is working its way down the clinical trial path, it is natural for a drug sponsor to want to communicate about its progress. But when it comes to pre-approval communications, there are some caveats, particularly respecting … Continue reading
Recently Merck announced a lowering of the price of Zocor (simvastatin) in a move that presumably will put their brand name drug in a competitive position vis a vis an upcoming generic product, just approved by the FDA. This brought … Continue reading
